Novel biomarker found in ovarian cancer patients can predict response to therapy
Researchers have identified an independent prognostic factor that is associated with extended, disease-free survival for women with advanced ovarian cancer.
Specific microbes in digestive tract can boost success for cancer immunotherapy
Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma. Patients with a higher ratio of the “beneficial” bacteria to “non-beneficial” bacteria all showed a clinical response: a reduction in tumor size.
